PRINCETON, N.J.— 2021年11月4日 — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation, today announced that seven of the Company’s scientists have been featured in a list of the top 2% of scientists worldwide. The list was published on 2021年10月19日 by Elsevier BV and Stanford University.
The ranking of scientists worldwide is based on a composite citation score or a percentile rank of 2% or above. Scientists are classified into 22 scientific fields and 176 sub-fields. The seven scientists at Certara, who were ranked on the list, were recognized in the fields of toxicology and pharmacology & pharmacy and a range of sub-fields, including endocrinology and metabolism, pediatrics, microbiology, chemistry, and medicinal and biomolecular.
“I would like to congratulate our scientific leaders not only for receiving this prestigious recognition but also for their significant contributions to pharmaceutical sciences and impact on drug development and ultimately patients,” said William F. Feehery, Ph.D., chief executive officer of Certara. “Science is at the foundation of what we do at Certara, and we have some of the world’s leading scientists working on the toughest challenges in drug development today.”
Certara（サターラ）について
サターラは、バイオシミュレーションソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。バイオ医薬品企業1,650社以上、主要学術機関、主要な規制当局がサターラのソフトウェアやコンサルティングサービスを利用しております。弊社のお客様は61か国以上に広がっております。
お問合せ先
Jieun Choe
Chief Strategy and Marketing Officer
jieun.choe@certara.com
